Download PDF
Exp Clin Endocrinol Diabetes 2003; 111(1): 41-43
DOI: 10.1055/s-2003-37499
Case Report

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

Unilateral Adrenal Tumor, Erectile Dysfunction and Infertility in a Patient with 21-Hydroxylase Deficiency: Effects of Glucocorticoid Treatment and Surgery

C. Scaroni 1 , G. Favia 2 , F. Lumachi 2 , G. Opocher 1 , G. Bonanni 1 , F. Mantero 1 , D. Armanini 1
  • 1Department of Endocrinology, University of Padova, Padova, Italy
  • 2Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
Further Information

Publication History

Received: September 14, 2001 First decision: January 8, 2002

Accepted: April 8, 2002

Publication Date:
26 February 2003 (online)

Also available at
    Permissions and Reprints

Abstract

In untreated congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21OHDS) the presence of adrenal and testicular tumors had been described; however little is known about the effect of the enzymatic defect on fertility in males.

We studied a male adult patient affected by 21OHDS for infertility, after a long period of discontinuation of glucocorticoid therapy and then during resumption of treatment and 8 months after monoadrenalectomy.

The initial spermatic count revealed azoospermia and testicular needle aspiration showed a cytological picture consistent with prepuberty. The morphofunctional study revealed a right adrenal mass with reduced uptake at radioscan.

Treatment was resumed with onset of impotency, which improved after reduction of the dose of glucocorticoids. The patient was monoadrenalectomised and his spermatic count increased. The patient shows that corticosteroid therapy in 21OHDS should be continued lifelong to avoid adrenal hyperplasia with possible areas of autonomy and to allow regular fertility. Impotence during treatment is probably due to a decrease of excessive adrenal androgens while testicular androgen production is still suppressed.

Key words

Adrenal mass - 21-Hydroxylase deficiency syndrome - Infertility - Impotence

References

  • 1 Jaresch S, Kornely E, Kley H, Schlaghecke R. Adrenal incidentaloma and patients with homozygous or heterozygous congenital adrenal hyperplasia.  J Clin Endocrinol Metab. 1992;  74 685-689
    CrossrefPubMedGoogle Scholar
  • 2 Merke D, Bornstein S, Braddock D, Chrousos G. Adrenal lymphocytic infiltration and adrenocortical tumors in patient with 21-hydroxylase deficiency.  New Engl J Med. 1999;  340 1121-1122
    CrossrefPubMedGoogle Scholar
  • 3 Mirsky H, Hines J. Infertility in a man with 21-hydroxylase deficient congenital adrenal hyperplasia.  J Urol. 1989;  142 111-113
    PubMedGoogle Scholar
  • 4 New M I. Steroid 21-hydroxylase deficiency (Congenital adrenal hyperplasia).  Am J Med. 1995;  98 2-8
    PubMedGoogle Scholar
  • 5 Pang S. Congenital adrenal hyperplasia.  Endocrinol Metab Clin North America. 1997;  26 853-891
    PubMedGoogle Scholar
  • 6 Stikkelbroeck N MML, Otten B J, Pasic A, Jager G J, Sweep C GJ, Noordam K, Hermus A RMM. High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia.  J Clin Endocrinol Metab. 2001;  86 5721-5728
    CrossrefPubMedGoogle Scholar
  • 7 Valentino R, Savastano S, Tomaselli A P, Carpitta M T, Dorato M, Gigante M, Calvanese E, Carlino M, Lombardi G. Success of glucocorticoid replacement therapy on fertility in two adult males with 21-CAH homozygote classic form.  J Endocrinol Invest. 1997;  20 690-694
    PubMedGoogle Scholar
  • 8 Wischusen J, Baker H, Hudson B. Reversible male infertility due to congenital adrenal hyperplasia.  Clin Endocrinol. 1981;  14 571-577
    PubMedGoogle Scholar

Dr. Carla Scaroni

Department of Endocrinology · University of Padova

via Ospedale 105

35100 Padova

Italy

Phone: +39/0498213018

Fax: +39/049657391

Email: carla.scaroni@unipd.it

      >